Niki BioSolutions posts H1 2026 net loss of $1.3M, flags going-concern doubt

Aptorum Group Ltd

H1 2026 net loss attributable to Niki was $1,326,004 vs $441,780 in H1 2025; EPS loss of $1.6.
Cash fell to $1,834,171 from $3,452,891 at Dec 31, 2025; operating cash outflow of $1,553,720.
Management disclosed substantial doubt about going concern within next 12 months; negative working capital of $2,475,418.
R&D expenses rose to $383,752 from $19,375 in H1 2025; related-party convertible notes total $3,508,500.
1-for-10 reverse stock split effective July 20, 2026; 1,979,216 shares issued to DiamiR stockholders.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.